Zobrazeno 1 - 10
of 88
pro vyhledávání: '"Ronald L. Alkana"'
Autor:
Karan H. Muchhala, Daya I. Perkins, Anna Naito, Gregg E. Homanics, James R. Trudell, Daryl L. Davies, Liana Asatryan, Ronald L. Alkana
Publikováno v:
Molecular Pharmacology. 86:635-646
A critical obstacle to developing effective medications to prevent and/or treat alcohol use disorders is the lack of specific knowledge regarding the plethora of molecular targets and mechanisms underlying alcohol (ethanol) action in the brain. To id
Autor:
Daryl L. Davies, Nhat Huynh, Liana Asatryan, Michael Neely, Megan M. Yardley, Ronald L. Alkana, Stan G. Louie
Publikováno v:
NeuroReport. 25:1018-1023
Ivermectin (IVM), an FDA approved anthelmintic agent, can significantly reduce ethanol intake in mice following acute administration. The current study evaluates the sustainability and safety of multiday IVM administration in reducing 10% v/v ethyl a
Autor:
James R. Trudell, Ronald L. Alkana, Sheraz Khoja, Megan M. Yardley, Nhat Hyunh, Nicos A. Petasis, Stan G. Louie, Liana Asatryan, Daryl L. Davies
Publikováno v:
The International Journal of Neuropsychopharmacology. 17:907-916
Our laboratory is investigating ivermectin (IVM) and other members of the avermectin family as new pharmaco-therapeutics to prevent and/or treat alcohol use disorders (AUDs). Prior work found that IVM significantly reduced ethanol intake in mice and
Autor:
Michael W. Jakowec, Sean C. Godar, Marco Bortolato, Daryl L. Davies, Letisha R. Wyatt, Ronald L. Alkana, Sheraz Khoja
Publikováno v:
Neuropsychopharmacology. 38:1993-2002
Purinergic P2X receptors are a family of ligand-gated ion channels gated by extracellular adenosine 5'-triphosphate (ATP). Of the seven P2X subtypes, P2X4 receptors (P2X4Rs) are richly expressed in the brain, yet their role in behavioral organization
Autor:
Ronald L. Alkana, Nhat Huynh, Sheraz Khoja, Megan M. Yardley, Nicos A. Petasis, Letisha R. Wyatt, Stan G. Louie, Deborah A. Finn, Marco Bortolato, Liana Asatryan, Daryl L. Davies, Marcia J. Ramaker
Publikováno v:
Neuropharmacology. 63:190-201
The high rate of therapeutic failure in the management of alcohol use disorders (AUDs) underscores the urgent need for novel and effective strategies that can deter ethanol consumption. Recent findings from our group showed that ivermectin (IVM), a b
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 341:543-551
Recent studies highlighted the importance of loop 2 of α1 glycine receptors (GlyRs) in the propagation of ligand-binding energy to the channel gate. Mutations that changed polarity at position 52 in the β hairpin of loop 2 significantly affected se
Autor:
Olga Ostrovskaya, Liana Asatryan, Kaixun Li, Ronald L. Alkana, Daryl L. Davies, Letisha R. Wyatt, Maya Popova, Robert W. Peoples
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 337:171-179
P2X receptors (P2XRs) are ion channels gated by synaptically released ATP. The P2X4 is the most abundant P2XR subtype expressed in the central nervous system and to date is the most ethanol-sensitive. In addition, genomic findings suggest that P2X4Rs
Publikováno v:
Pharmacology & Therapeutics. 127:53-65
Glycine receptors (GlyRs) are recognized as the primary mediators of neuronal inhibition in the spinal cord, brain stem and higher brain regions known to be sensitive to ethanol. Building evidence supports the notion that ethanol acting on GlyRs caus
Autor:
Ronald L. Alkana, Olga Ostrovskaya, Maya Popova, Daryl L. Davies, Kaixun Li, Liana Asatryan, Letisha R. Wyatt
Publikováno v:
Journal of Neurochemistry. 112:307-317
J. Neurochem. (2010) 112, 307–317. Abstract ATP-gated P2X4 receptors (P2X4R) are abundantly expressed in the CNS. However, little is known about the molecular targets for ethanol action in P2X4Rs. The current investigation tested the hypothesis tha
Targets for ethanol action and antagonism in Loop 2 of the extracellular domain of glycine receptors
Publikováno v:
Journal of Neurochemistry. 106:1337-1349
The present studies used increased atmospheric pressure in place of a traditional pharmacological antagonist to probe the molecular sites and mechanisms of ethanol action in glycine receptors (GlyRs). Based on previous studies, we tested the hypothes